TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 EUR)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
51
|
53
|
59 |
| Financial expenses |
1
|
0
|
4 |
| Earnings before taxes |
47
|
6
|
5 |
| EBITDA |
-2
|
0
|
9 |
| Total assets |
303
|
276
|
275 |
| Current assets |
19
|
35
|
25 |
| Current liabilities |
25
|
24
|
15 |
| Equity capital |
268
|
240
|
246 |
| - share capital |
9
|
9
|
8 |
| Employees (average) |
0
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
88.4%
|
87.0%
|
89.5% |
| Turnover per employee |
53
|
59 | |
| Profit as a percentage of turnover |
92.2%
|
11.3%
|
8.5% |
| Return on assets (ROA) |
15.8%
|
2.2%
|
3.3% |
| Current ratio |
76.0%
|
145.8%
|
166.7% |
| Return on equity (ROE) |
17.5%
|
2.5%
|
2.0% |
| Change turnover |
-3
|
-8
|
-36 |
| Change turnover % |
-5%
|
-12%
|
-38% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.